JPRN-UMIN000007548已完成2 期
Phase II study of zoledronic acid concomitant with androgen deprivation therapy for patients with treatment-naive bone-metastatic prostate cancer - Zoledronic acid with ADT for treatment-naive bone-metastatic prostate cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Symptomatic central nervous system metastases. Coagulation disorders. Infection requiring intravenous antibiotics. Radiologically proved interstitial pneumonitis. Clinically significant cardiovascular disease. Pleural or pericardial effusion Dental problem requiring invasive treatment. History of bisphosphonate. History of another malignancy within the preceding 5 years.
研究者
相似试验
招募中
2 期
Phase II study of neoadjuvant zoledronic acid therapy for early breast cancer patientsearly breast cancerJPRN-UMIN000003493Division of Medical Oncology and Breast Surgery, Cancer Institute Hospital30
招募中
2 期
A phase II clinical trial of zoledronic acid treatment for advanced non-small cell lung cancer with bone metastasis.on-small cell lung cancerJPRN-UMIN000006935Dokkyo Medical University School of Medicine, Department of Pulmonary Medicine and Clinical Immunology40
已完成
Unknown
A new study to minimise the side effects of rapid maxillary expansioSide effects of rapid maxillary expansion (RME) on dental and buccal alveolar bone changesOral HealthISRCTN16744226Damascus University32
已完成
不适用
Zoledronic acid injection prevents bone loss in spinal cord injury patientsCTRI/2018/03/012408Dr Satyaranjan Sethi60
已完成
2 期
ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerBreast CancerBreast DiseaseNeoplasmsNeoplasms by SiteNCT01472146Susanne Crocamo58